Berberine
Berberine (BBR) is a naturally occurring isoquinoline alkaloid belonging to the protoberberine class, found in several medicinal plants including Berberis, Coptis chinensis, and Coscinium fenestratum.
Berberine (BBR) is a naturally occurring isoquinoline alkaloid belonging to the protoberberine class, found in several medicinal plants including Berberis, Coptis chinensis, and Coscinium fenestratum. It is characterized by a distinctive yellow color and a quaternary ammonium structure that enables intercalation into nucleic acids, binding to G-quadruplex (G4) DNA structures, and interaction with a broad spectrum of protein targets. Historically significant in traditional Asian medicine for its antimicrobial and anti-inflammatory properties, berberine has attracted sustained scientific attention for its pleiotropic pharmacological effects spanning metabolic regulation, anti-inflammatory signaling, and antineoplastic activity.
Mechanistically, berberine modulates multiple oncogenic and inflammatory cascades including the PI3K/Akt signaling pathway, the β-catenin/TCF4 axis, nuclear factor kappa B (NF-κB) signaling, and the CD44/JAK2/STAT3 signaling pathway. Its ability to intercalate into DNA and compete for nucleic acid-binding sites makes it a structurally versatile scaffold for targeting both protein–DNA and protein–protein interactions relevant to cancer and infectious disease. These properties, combined with a favorable safety profile relative to synthetic chemotherapeutics, have positioned berberine as a compound of significant translational interest across oncology, immunology, and antiviral research.
Where the papers sit
16 papers from the last 6 months study berberine directly · updated from PubMed 16 Nov 2026
Study type 0 clinical trials · 3 human data · 12 preclinical · 1 unclassified
Themes no clear themes
Those 16 do not share a common subject.
-
Berberine appears here across cognition, cancer, infection, metabolic disease, formulation, and chemical analysis. The recurring link is use of the alkaloid or related protoberberines, with mechanisms ranging from oxidative stress and mitophagy to ferroptosis, DNA repair, and membrane interaction. Delivery systems, computational prediction, and pharmacokinetic profiling recur alongside efficacy experiments. No single disease, mechanism, endpoint, or research direction unifies the cluster.
Papers
The 16 papers from the last 6 months that study berberine directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
No clear themes (16)
- Berberine improves cognitive impairment in diabetic mice by mitigating 4-HNE-induced oxidative stress and enhancing hippocampal insulin sensitivity. Molecular biology reports · 30 Oct 2026 PMID 42961528
- Synergistic Berberine/Pirfenidone-Loaded Thermosensitive Hydrogel: Integrated Antibacterial Defense Activity and Pirfenidone-Mediated Angiogenesis for Efficient Diabetic Wound Repair. ACS applied bio materials · 29 Oct 2026 PMID 42954794
- An integrated prediction model using machine learning and dynamics simulation for the selection of transdermal penetration enhancers. Journal of controlled release : official journal of the Controlled Release Society · 11 Oct 2026 PMID 42860200
- Network pharmacology, single-cell transcriptomics, machine learning and experimental validation identifying CHEK2 and HPGD as key therapeutic targets of berberine in diabetic nephropathy. Functional & integrative genomics · 1 Oct 2026 PMID 42821141
- Mechanism of Aggregation-Induced Emission of Berberine and Palmatine in Aqueous Solution. The journal of physical chemistry. B · 10 Sept 2026 PMID 42720359
- Berberine Modulates Mitophagy-Related Gene Expression and Suppresses Breast Cancer Cells: A Multi-Omics and Experimental Study. Cell biochemistry and biophysics · 26 Aug 2026 PMID 42645668
- Berberine and lactulose combination therapy attenuates neuroinflammation and hepatic injury in thioacetamide-induced hepatic encephalopathy in rats. Metabolic brain disease · 19 Aug 2026 PMID 42616213
- Towards macrophage-oriented Antituberculosis therapy: nanohydrogel and liposomal delivery of rifampicin-berberine Co-nanocrystals for enhanced intracellular Antituberculosis activity. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 18 Aug 2026 PMID 42612927
- Structure-Activity Relationship Study of Protoberberine Alkaloids Reveals Molecular Planarity as a Key Determinant of Membrane Interaction and Protection from Misfolded Protein Oligomers. Journal of medicinal chemistry · 13 Aug 2026 PMID 42593899
- Berberine attenuates hyperglycemia induced neurodegeneration in mice by modulation of Nrf2 expression. Molecular biology reports · 23 Jun 2026 PMID 42334690
- Identification of chemical components in Thalictrum glandulosissimum using UPLC-Q-TOF-MS/MS and pharmacokinetic analysis of multiple alkaloids in normal and ulcerative colitis rats. Journal of pharmaceutical and biomedical analysis · 22 Jun 2026 PMID 42330697
- Mechanism of berberine in the treatment of polycystic ovary syndrome revealed by network pharmacology analysis: Focusing on ferroptosis, ROS, immunity and inflammation. Biochemical and biophysical research communications · 14 Jun 2026 PMID 42289176
- Bioactivity-guided isolation of anti-adipogenic diarylpentanoids from Rhamnoneuron balansae. Fitoterapia · 2 Jun 2026 PMID 42229863
- Imaging-guided spatiotemporal profiling of berberine's inter-organellar translocation and hepatocellular carcinoma inhibition mechanism. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 27 May 2026 PMID 42202737
- Berberine impedes the DNA damage repair to inhibit colorectal cancer by regulating the SOX17/TCF4/PIM3 axis. Molecular genetics and genomics : MGG · 27 May 2026 PMID 42201413
- Linking intestinal distribution to pharmacological mechanism: Berberine prevents and treats colorectal cancer by targeting SIGMAR1. Phytomedicine : international journal of phytotherapy and phytopharmacology · 22 May 2026 PMID 42172984
By study type
Human data, design not indexed (3)
- Network pharmacology, single-cell transcriptomics, machine learning and experimental validation identifying CHEK2 and HPGD as key therapeutic targets of berberine in diabetic nephropathy. Functional & integrative genomics · 1 Oct 2026 PMID 42821141
- Towards macrophage-oriented Antituberculosis therapy: nanohydrogel and liposomal delivery of rifampicin-berberine Co-nanocrystals for enhanced intracellular Antituberculosis activity. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 18 Aug 2026 PMID 42612927
- Imaging-guided spatiotemporal profiling of berberine's inter-organellar translocation and hepatocellular carcinoma inhibition mechanism. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 27 May 2026 PMID 42202737
Preclinical: animal, cell and lab studies (12)
- Berberine improves cognitive impairment in diabetic mice by mitigating 4-HNE-induced oxidative stress and enhancing hippocampal insulin sensitivity. Molecular biology reports · 30 Oct 2026 PMID 42961528
- Synergistic Berberine/Pirfenidone-Loaded Thermosensitive Hydrogel: Integrated Antibacterial Defense Activity and Pirfenidone-Mediated Angiogenesis for Efficient Diabetic Wound Repair. ACS applied bio materials · 29 Oct 2026 PMID 42954794
- An integrated prediction model using machine learning and dynamics simulation for the selection of transdermal penetration enhancers. Journal of controlled release : official journal of the Controlled Release Society · 11 Oct 2026 PMID 42860200
- Mechanism of Aggregation-Induced Emission of Berberine and Palmatine in Aqueous Solution. The journal of physical chemistry. B · 10 Sept 2026 PMID 42720359
- Berberine and lactulose combination therapy attenuates neuroinflammation and hepatic injury in thioacetamide-induced hepatic encephalopathy in rats. Metabolic brain disease · 19 Aug 2026 PMID 42616213
- Structure-Activity Relationship Study of Protoberberine Alkaloids Reveals Molecular Planarity as a Key Determinant of Membrane Interaction and Protection from Misfolded Protein Oligomers. Journal of medicinal chemistry · 13 Aug 2026 PMID 42593899
- Berberine attenuates hyperglycemia induced neurodegeneration in mice by modulation of Nrf2 expression. Molecular biology reports · 23 Jun 2026 PMID 42334690
- Identification of chemical components in Thalictrum glandulosissimum using UPLC-Q-TOF-MS/MS and pharmacokinetic analysis of multiple alkaloids in normal and ulcerative colitis rats. Journal of pharmaceutical and biomedical analysis · 22 Jun 2026 PMID 42330697
- Mechanism of berberine in the treatment of polycystic ovary syndrome revealed by network pharmacology analysis: Focusing on ferroptosis, ROS, immunity and inflammation. Biochemical and biophysical research communications · 14 Jun 2026 PMID 42289176
- Bioactivity-guided isolation of anti-adipogenic diarylpentanoids from Rhamnoneuron balansae. Fitoterapia · 2 Jun 2026 PMID 42229863
- Berberine impedes the DNA damage repair to inhibit colorectal cancer by regulating the SOX17/TCF4/PIM3 axis. Molecular genetics and genomics : MGG · 27 May 2026 PMID 42201413
- Linking intestinal distribution to pharmacological mechanism: Berberine prevents and treats colorectal cancer by targeting SIGMAR1. Phytomedicine : international journal of phytotherapy and phytopharmacology · 22 May 2026 PMID 42172984
Unclassified: not yet indexed with MeSH (1)
- Berberine Modulates Mitophagy-Related Gene Expression and Suppresses Breast Cancer Cells: A Multi-Omics and Experimental Study. Cell biochemistry and biophysics · 26 Aug 2026 PMID 42645668
Written from 16 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-09-12 by GPT. Drafted by language models from published abstracts; not medical advice.